Isavuconazole + dextromethorphan
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics of Isavuconazole
Conditions
Pharmacokinetics of Isavuconazole, Pharmacokinetics of Dextromethorphan, Healthy Adult Volunteers
Trial Timeline
May 1, 2012 → May 1, 2012
NCT ID
NCT01651325About Isavuconazole + dextromethorphan
Isavuconazole + dextromethorphan is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of Isavuconazole. The current trial status is completed. This product is registered under clinical trial identifier NCT01651325. Target conditions include Pharmacokinetics of Isavuconazole, Pharmacokinetics of Dextromethorphan, Healthy Adult Volunteers.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics of Isavuconazole were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01651325 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics of Isavuconazole